复方血栓通胶囊联合复方倍他米松治疗口腔扁平苔藓临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R758.65

基金项目:


Clinical Study on Compound Xueshuantong Capsules Combined with Compound Betamethasone for Oral Lichen Planus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复方血栓通胶囊联合复方倍他米松治疗口腔扁平苔藓的临床疗效及对血清炎症因子水 平的影响。方法:按随机数字表法将88 例口腔扁平苔藓患者分为对照组和治疗组各44 例。对照组采取复方倍 他米松治疗,治疗组在对照组基础上联合复方血栓通胶囊治疗。2 组疗程均为1 个月。比较2 组治疗前后症状 体征评分、疼痛视觉模拟评分法(VAS) 评分、血液流变学指标、炎症因子[白细胞介素-2(IL-2)、白细胞 介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)] 水平,并分析临床疗效及不良反应情况。结果:治疗组总有 效率为97.73%,对照组为84.09%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组症状体征、VAS 评分均较治疗前降低(P<0.05),且治疗组症状体征、VAS 评分低于对照组(P<0.05)。治疗后,2 组血浆黏 度、纤维蛋白原、血小板聚集率、红细胞压积水平均较治疗前降低(P<0.05),且治疗组上述各项指标均低于 对照组(P<0.05)。治疗后,2 组血清IL-2、IL-10、TNF-α 水平均较治疗前降低(P<0.05),且治疗组上述 各项指标均低于对照组(P<0.05)。治疗组不良反应发生率为4.55%,对照组为11.36%,2 组比较,差异无统 计学意义(P>0.05)。结论:复方血栓通胶囊联合复方倍他米松治疗口腔扁平苔藓疗效肯定,能有效抑制机体 炎症反应,改善患者临床症状体征及血液高黏状态,明显减轻疼痛,且不良反应相对较少。

    Abstract:

    Abstract:Objective:To observe the curative effect of Compound Xueshuantong Capsules combined with Compound Betamethasone for oral lichen planus and its effect on the levels of serum inflammatory factors. Methods:A total of 88 cases of oral lichen planus patients were divided into the control group and the treatment group according to the random number table method, with 44 cases in each group. The control group was treated with Compound Betamethasone and the treatment group was additionally treated with Compound Xueshuantong Capsules based on the treatment of the control group. Both groups were treated for one month. The scores of symptoms and signs, Visual Analogue Scale (VAS) scores , hemorheology indexes , and levels of inflammatory factors including interleukin- 2 (IL- 2) , interleukin- 10 (IL- 10),and tumor necrosis factor- α (TNF- α) were compared before and after treatment between the two groups;clinical effects and adverse reactions were analyzed. Results:The total effective rate was 97.73% in the treatment group and 84.09% in the control group,the difference being significant (P<0.05). After treatment,the scores of symptoms,signs,and VAS in the two groups were decreased when compared with those before treatment, and the above scores in the treatment group were lower than those in the control group (P<0.05). After treatment, the levels of plasma viscosity, fibrinogen, platelet aggregation rates,and hematocrit in the two groups were decreased when compared with those before treatment (P<0.05), and the above indexes in the treatment group were lower than those in the control group (P<0.05). After treatment, the levels of IL- 2, IL- 10, and TNF- α in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the above indexes in the treatment group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 4.55% in the treatment group and 11.36% in the control group, there being no significant difference between the two groups (P>0.05). Conclusion:Compound Xueshuantong Capsules combined with Compound Betamethasone has a definite curative effect in the treatment of oral lichen planus,which can effectively inhibit the inflammatory responses of the body, improve the clinical signs and symptoms and high blood agglutination state of patients and significantly reduce pain, with relatively fewer adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

封亚萍,张兵,董斌.复方血栓通胶囊联合复方倍他米松治疗口腔扁平苔藓临床研究[J].新中医,2023,55(12):110-114

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-06-27
  • 出版日期:
文章二维码